Evidence map›Paper›PMID 33785863›Full record

ArticleLeukemia2021

Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia.

Sofie Lundgren, Mikko A I Keränen, Matti Kankainen, Jani Huuhtanen, Gunilla Walldin, Cassandra M Kerr, Michael Clemente, Freja Ebeling, Hanna Rajala, Oscar Brück and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Leukemia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Detection and Characterization of Clonal Hematopoiesis.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. The highs and lows of cyclic thrombocytopenia.British journal of haematology · 2024
    Review
  16. Review
  17. TGF-β-p-STAT1-LAIR2 axis has a "self-rescue" role for exhausted CD8Cellular oncology (Dordrecht, Netherlands) · 2023
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 4 countries.

Sofie Lundgren *Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland. sofie.lundgren@helsinki.fi.ORCID http://orcid.org/0000-0003-3146-9816
Mikko A I Keränen *Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland. mikko.a.keranen@helsinki.fi.
Matti KankainenHematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.ORCID http://orcid.org/0000-0002-4714-9481
Jani HuuhtanenHematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.ORCID http://orcid.org/0000-0003-2750-4033
Gunilla WalldinCenter for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.
Cassandra M KerrTranslational Hematology and Oncology Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
Michael ClementeTranslational Hematology and Oncology Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
Freja EbelingDepartment of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
Hanna RajalaHematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
Oscar BrückHematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.ORCID http://orcid.org/0000-0002-7842-9419
Harri LähdesmäkiDepartment of Computer Science, School of Science, Aalto University, Espoo, Finland.
Sari HannulaInstitute of Molecular Medicine Finland, HILIFE, University of Helsinki, Helsinki, Finland.
Tiina HannunenInstitute of Molecular Medicine Finland, HILIFE, University of Helsinki, Helsinki, Finland.
Pekka EllonenInstitute of Molecular Medicine Finland, HILIFE, University of Helsinki, Helsinki, Finland.
Neal S YoungHematology Branch, National Heart Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD, USA.
Seishi OgawaPathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Jaroslaw P Maciejewski *Translational Hematology and Oncology Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-6837-4346
Eva Hellström-Lindberg *Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.
Satu MustjokiHematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland. satu.mustjoki@helsinki.fi.ORCID http://orcid.org/0000-0002-0816-8241
University of Helsinki · FICleveland Clinic · USKarolinska University Hospital · SEAalto University · FIHelsinki University Hospital · FIKyoto University · JPNational Institutes of Health · US

Funding

Pathogenesis And Treatment Of Aplastic AnemiaZIAHL002315 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI YOUNG, NEAL S · 2009 to 2025
$60.1M
6 · The paper itself

Abstract

The prevalence and functional impact of somatic mutations in nonleukemic T cells is not well characterized, although clonal T-cell expansions are common. In immune-mediated aplastic anemia (AA), cytotoxic T-cell expansions are shown to participate in disease pathogenesis. We investigated the mutation profiles of T cells in AA by a custom panel of 2533 genes. We sequenced CD4+ and CD8+ T cells of 24 AA patients and compared the results to 20 healthy controls and whole-exome sequencing of 37 patients with AA. Somatic variants were common both in patients and healthy controls but enriched to AA patients' CD8+ T cells, which accumulated most mutations on JAK-STAT and MAPK pathways. Mutation burden was associated with CD8+ T-cell clonality, assessed by T-cell receptor beta sequencing. To understand the effect of mutations, we performed single-cell sequencing of AA patients carrying STAT3 or other mutations in CD8+ T cells. STAT3 mutated clone was cytotoxic, clearly distinguishable from other CD8+ T cells, and attenuated by successful immunosuppressive treatment. Our results suggest that somatic mutations in T cells are common, associate with clonality, and can alter T-cell phenotype, warranting further investigation of their role in the pathogenesis of AA.

Indexed as

AdultAgedAged, 80 and overAnemia, AplasticCase-Control StudiesCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesFemaleHumansMaleMiddle AgedMutationYoung Adult

Identifiers

PMID33785863
PMCPMC8102188
OpenAlexW3152165220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.